tradingkey.logo

Merit Medical Systems Inc

MMSI
查看详细走势图
87.390USD
-0.240-0.27%
收盘 12/24, 16:00美东报价延迟15分钟
5.18B总市值
43.52市盈率 TTM

Merit Medical Systems Inc

87.390
-0.240-0.27%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.27%

5天

-0.09%

1月

-0.24%

6月

-5.68%

今年开始到现在

-9.65%

1年

-10.90%

查看详细走势图

TradingKey Merit Medical Systems Inc股票评分

单位: USD 更新时间: 2025-12-24

操作建议

Merit Medical Systems Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名12/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价103.00。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Merit Medical Systems Inc评分

相关信息

行业排名
12 / 206
全市场排名
69 / 4562
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 11 位分析师
买入
评级
103.000
目标均价
+23.93%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Merit Medical Systems Inc亮点

亮点风险
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
业绩高增长
公司营业收入稳步增长,连续3年增长17.86%
利润高增长
公司净利润处于行业前列,最新年度总收入1.36B美元
估值低估
公司最新PE估值43.52,处于3年历史低位
机构减仓
最新机构持股64.29M股,环比减少5.30%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓,最新持仓市值142.00
活跃度降低
近期活跃度降低,过去20天平均换手率-0.08

Merit Medical Systems Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Merit Medical Systems Inc简介

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
公司代码MMSI
公司Merit Medical Systems Inc
CEOAronson (Martha Goldberg)
网址https://www.merit.com/

常见问题

Merit Medical Systems Inc(MMSI)的当前股价是多少?

Merit Medical Systems Inc(MMSI)的当前股价是 87.390。

Merit Medical Systems Inc的股票代码是什么?

Merit Medical Systems Inc的股票代码是MMSI。

Merit Medical Systems Inc股票的52周最高点是多少?

Merit Medical Systems Inc股票的52周最高点是111.450。

Merit Medical Systems Inc股票的52周最低点是多少?

Merit Medical Systems Inc股票的52周最低点是78.116。

Merit Medical Systems Inc的市值是多少?

Merit Medical Systems Inc的市值是5.18B。

Merit Medical Systems Inc的净利润是多少?

Merit Medical Systems Inc的净利润为120.36M。

现在Merit Medical Systems Inc(MMSI)的股票是买入、持有还是卖出?

根据分析师评级,Merit Medical Systems Inc(MMSI)的总体评级为买入,目标价格为103.000。

Merit Medical Systems Inc(MMSI)股票的每股收益(EPS TTM)是多少

Merit Medical Systems Inc(MMSI)股票的每股收益(EPS TTM)是2.008。
KeyAI